---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-24-000237"
form_type: "8-K"
ticker: "ADCT"
cik: "0001771910"
company_name: "ADC Therapeutics SA"
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T04:08:21.507063+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ADC Therapeutics regains NYSE minimum bid price compliance; removed from noncompliant list

## Summary
- Received NYSE notice on Jan 2, 2024 confirming compliance with Section 802.01C.
- Cure: closing price on Dec 29, 2023 and 30-trading-day average both above $1.00.
- Previously noncompliant due to average closing price below $1.00 over 30 days.
- Company will be removed from NYSE's noncompliant issuers list.

## SEC filing metadata
- accession: 0000950103-24-000237
- form_type: 8-K
- ticker: ADCT
- cik: 0001771910
- company_name: ADC Therapeutics SA
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771910/000095010324000237/0000950103-24-000237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771910/000095010324000237/dp204732_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-24-000237
- JSON: https://secwatch.observer/filing/0000950103-24-000237.json
- Plain text: https://secwatch.observer/filing/0000950103-24-000237.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.